Yıl: 2020 Cilt: 44 Sayı: 6 Sayfa Aralığı: 1674 - 1693 Metin Dili: İngilizce DOI: 10.3906/kim-2009-1 İndeks Tarihi: 24-06-2022

Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives

Öz:
In this study, a group of 4-substituted benzoyltaurinamide derivatives were designed, synthesized, and investigated for their anticancer activity against three cancer cell lines and one nontumorigenic cell line by MTT assay. Among the final compounds, methoxyphenyl derivatives 14, 15, 16 were found to be effective against all the tested cancerous cell lines with promising selectivity. The most active compounds were further evaluated to determine the molecular mechanism of their anticancer activity by using western blot assay and the Annexin V-FITC/PI test. Compound 14 (in SH-SY5Y and MDA-MB-231 cell lines) and 15 (in SH-SY5Y cell line) were found to induce intrinsic apoptotic pathway by upregulating BAX, caspase-3, and caspase-9, while downregulating Bcl-2 and Bcl-xL expression levels. According to mechanistic studies, compounds displayed their anticancer activity via three different mechanisms: a. caspase-dependent, b. caspase-independent, and c. caspase-dependent pathway that excluded caspase-9 activation. As a result, this study provides interesting data which can be used to design new taurine-based anticancer derivatives.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018; 68: 394-424.
  • 2. Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmaceutical Bulletin 2017; 7: 339-348.
  • 3. Narang AS, Desai DS. Anticancer drug development unique aspects of pharmaceutical development. In: Lu Y, Mahato RI (editors). Pharmaceutical Perspectives of Cancer Therapeutics. New York, NY, USA: Springer, 2009: 49-92.
  • 4. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
  • 5. Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biology 2016; 37: 8471- 8486.
  • 6. Ichim G, Tait SWG. A fate worse than death: Apoptosis as an oncogenic process. Nature Reviews Cancer 2016; 16: 539-548.
  • 7. Bai L, Chen J, McEachern D, Liu L, Zhou H et al. BM-1197: A novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and longlasting tumor regression in vivo. PLoS ONE 2014; 9: e99404.
  • 8. Roth SH, Hergenrother JP. Derivatives of procaspase-activating compound 1 (PAC-1) and their anticancer activities. Current Medicinal Chemistry 2016; 23: 201-241.
  • 9. Chen K, Zhang Q, Wang J, Liu F, Mi M et al. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Research 2009; 1279: 131-138.
  • 10. Vanitha MK, Baskaran K, Periyasamy K, Saravanan D, Ilakkia A et al. A review on the biomedical importance of taurine. International Journal of Pharma Research and Health Sciences 2015; 3: 680-686.
  • 11. Zhang X, Tu S, Wang Y, Xu B, Wan F. Mechanism of taurine-induced apoptosis in human colon cancer cells. Acta Biochimica et Biophysica Sinica 2014; 46: 261-272.
  • 12. Tu S, Zhang X, Wan H, Xia Y, Liu Z et al. Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells. Oncology Letters 2018; 15: 5473-5480.
  • 13. Srivastava S, Roy R, Singh S, Kumarb P, Dalela D et al. Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: a pilot study by 1H NMR spectroscopy. Cancer Biomarkers 2009; 6: 11-20.
  • 14. El Agouza IM, Eissa SS, El Houseini MM, El-Nashar DE, Abd El Hameed OM. Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients. Angiogenesis 2011; 14: 321-330.
  • 15. Kontro P, Linden IB, Gothoni G, Oja SS. Novel anticonvulsant taurine derivatives. Progress in Clinical and Biological Research 1983; 125: 211-220.
  • 16. Neary PM, Hallihan P, Wang JH, Pfirrmann RW, Bouchier-Hayes DJ et al. The evolving role of taurolidine in cancer therapy. Annals of Surgical Oncology 2010; 17: 1135-1143.
  • 17. Gunnarsson PO, Vibe-Petersen J, Macpherson JS, Warrington PS, Polacek P et al. Pharmacokinetics of tauromustine in cancer patients. Cancer Chemotherapy and Pharmacology 1989; 23: 176-180.
  • 18. Calabresi P, Goulette FA, Darnowski JW. Taurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent. Cancer Research 2001; 61: 6816-6821.
  • 19. Rapport MM, Mead JF, Maynard JT, Senear AE, Koepfli JB. Derivatives of taurine and β-Alanine 1. Journal of the American Chemical Society 1947; 69: 2561-2563.
  • 20. Gupta RC. Taurine analogues and taurine transport: therapeutic advantages. In: Oja SS, Saransaari P, (editors). Taurine 6. New York, NY, USA: Springer US, 2006: 449-467.
  • 21. Della Corte L, Crichton RR, Duburs G, Nolan K, Tipton KF et al. The use of taurine analogues to investigate taurine functions and their potential therapeutic applications. Amino acids 2002; 23: 367-379.
  • 22. Winterbottom R, Clapp JW, Miller WH, English JP, Roblin RO. Studies in Chemotherapy. XV. Amides of Pantoyltaurine 1. Journal of the American Chemical Society 1947; 69: 1393-1401.
  • 23. Smits RA, Adami M, Istyastono EP, Zuiderveld OP,‡ vanDam CME et al. Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H 4 receptor inverse agonists. Journal of Medicinal Chemistry 2010; 53: 2390-2400.
  • 24. Curley OMS, McCormick JE, McElhinney RS, McMurry TBH. Intermediates in the Ing-Manske reaction. Arkivoc 2003; 2003: 180-189.
  • 25. Akgül O, Ozturk I, Aygül A, Ermertcan S. Synthesis and antimicrobial activity of some taurinamide derivatives. Marmara Pharmaceutical Journal 2017; 21: 361-370.
  • 26. Akgul O, Sultan Kilic F, Erol K, Pabuccuoglu V. Synthesis and anticonvulsant activity of some N-Phenyl-2-phtalimidoethanesulfonamide derivatives. Archiv der Pharmazie 2007; 340: 656-660.
  • 27. Kassab AE, Hassan RA. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition. Bioorganic Chemistry 2018; 80: 531-544.
  • 28. Pistritto G, Trisciuoglio D, Ceci C, Alessia Garufi, D’Orazi G. Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging 2016; 8: 603-619.
  • 29. Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nature Reviews Drug Discovery 2017; 16: 273-284.
  • 30. Domracheva I, Kanepe-Lapsa I, Jackevica L, Vasiljeva J, Arsenyan P. Selenopheno quinolinones and coumarins promote cancer cell apoptosis by ROS depletion and caspase-7 activation. Life Sciences 2017; 186: 92-101.
  • 31. Badland M, Crook R, Delayre B, Fussell SJ, Gladwell I et al. A comparative study of amide-bond forming reagents in aqueous media – Substrate scope and reagent compatibility. Tetrahedron Letters 2017; 58: 4391-4394.
  • 32. Akgül Ö, Angeli A, Vullo D, Carta F, Supuran CT. Unconventional amino acids in medicinal chemistry: first report on taurine merged within carbonic anhydrase inhibitors. Bioorganic Chemistry 2020; 103: 104236. doi: 10.1016/j.bioorg.2020.104236
  • 33. Oja SS, Kontro P, Lindén I-B, Gothóni G. Anticonvulsant activity of some 2-aminoethanesulphonic acid (taurine) derivatives. European Journal of Pharmacology 1983; 87: 191-198.
  • 34. Chen N, Xu J. HCOOH, an inexpensive, convenient, and practical 13C NMR solvent for strong polar amino acids and their derivatives. Letters in Organic Chemistry 2009; 6: 349-353.
  • 35. Miller E, Sprague JM, Kissinger LW, McBurney LF. The preparation of some amino sulfonamides. Journal of the American Chemical Society 1940; 62: 2099-2103.
  • 36. Andersen L, Sundman LO, Linden IB, Kontro P, Oja SS. Synthesis and anticonvulsant properties of some 2-aminoethanesulfonic acid (taurine) derivatives. Journal of Pharmaceutical Sciences 1984; 73: 106-108.
APA Akgul O, Erdogan M, Birim D, Kayabasi C, Gunduz C, ARMAGAN G (2020). Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. , 1674 - 1693. 10.3906/kim-2009-1
Chicago Akgul Ozlem,Erdogan Mumin,Birim Dervis,Kayabasi Cagla,Gunduz Cumhur,ARMAGAN GÜLİZ Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. (2020): 1674 - 1693. 10.3906/kim-2009-1
MLA Akgul Ozlem,Erdogan Mumin,Birim Dervis,Kayabasi Cagla,Gunduz Cumhur,ARMAGAN GÜLİZ Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. , 2020, ss.1674 - 1693. 10.3906/kim-2009-1
AMA Akgul O,Erdogan M,Birim D,Kayabasi C,Gunduz C,ARMAGAN G Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. . 2020; 1674 - 1693. 10.3906/kim-2009-1
Vancouver Akgul O,Erdogan M,Birim D,Kayabasi C,Gunduz C,ARMAGAN G Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. . 2020; 1674 - 1693. 10.3906/kim-2009-1
IEEE Akgul O,Erdogan M,Birim D,Kayabasi C,Gunduz C,ARMAGAN G "Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives." , ss.1674 - 1693, 2020. 10.3906/kim-2009-1
ISNAD Akgul, Ozlem vd. "Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives". (2020), 1674-1693. https://doi.org/10.3906/kim-2009-1
APA Akgul O, Erdogan M, Birim D, Kayabasi C, Gunduz C, ARMAGAN G (2020). Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. Turkish Journal of Chemistry, 44(6), 1674 - 1693. 10.3906/kim-2009-1
Chicago Akgul Ozlem,Erdogan Mumin,Birim Dervis,Kayabasi Cagla,Gunduz Cumhur,ARMAGAN GÜLİZ Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. Turkish Journal of Chemistry 44, no.6 (2020): 1674 - 1693. 10.3906/kim-2009-1
MLA Akgul Ozlem,Erdogan Mumin,Birim Dervis,Kayabasi Cagla,Gunduz Cumhur,ARMAGAN GÜLİZ Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. Turkish Journal of Chemistry, vol.44, no.6, 2020, ss.1674 - 1693. 10.3906/kim-2009-1
AMA Akgul O,Erdogan M,Birim D,Kayabasi C,Gunduz C,ARMAGAN G Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. Turkish Journal of Chemistry. 2020; 44(6): 1674 - 1693. 10.3906/kim-2009-1
Vancouver Akgul O,Erdogan M,Birim D,Kayabasi C,Gunduz C,ARMAGAN G Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. Turkish Journal of Chemistry. 2020; 44(6): 1674 - 1693. 10.3906/kim-2009-1
IEEE Akgul O,Erdogan M,Birim D,Kayabasi C,Gunduz C,ARMAGAN G "Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives." Turkish Journal of Chemistry, 44, ss.1674 - 1693, 2020. 10.3906/kim-2009-1
ISNAD Akgul, Ozlem vd. "Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives". Turkish Journal of Chemistry 44/6 (2020), 1674-1693. https://doi.org/10.3906/kim-2009-1